Exchange: NASDAQ·Updated 07:41 PM EST

PSTX Poseida Therapeutics Inc

$9.50
$0.06
(0.63%)
Today
Closed $9.50
$0.04
(0.42%)
After Hours
Reported EarningsNov 7
Mkt Cap$925.92M
Vol21.42M

About PSTX

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
53

Neutral Sentiment

How do you feel about PSTX?

Advertisement|Remove ads.